person

Per Loegstrup P.

Country
Denmark
Department
Steno Diabetes Center Aarhus

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
7
Sites with multiple studies

Has run more than one trial at 7 of 306 partner sites.

Specializations

Cardiovascular Health

The investigator specializes in preventive cardiology with particular emphasis on heart failure prevention and innovative therapeutic combinations. Their research explores the effectiveness of combination therapies in reducing cardiovascular mortality risks.

  • Heart Failure Risk Management
  • Cardiovascular Death Prevention
  • Combination Therapy Approaches

Their work involves evaluating novel therapeutic strategies for patients at elevated risk of developing cardiac complications.

Diabetes Care

The investigator focuses on type 2 diabetes management with particular attention to its cardiovascular complications. Their research encompasses screening methodologies for early detection of coronary artery disease in diabetic patients.

  • Subclinical Coronary Artery Disease
  • Diabetes-Related Cardiovascular Complications
  • Preventive Screening Strategies

Their expertise includes developing imaging-based intervention strategies for diabetes patients without known cardiovascular disease.

Diagnostic Innovation

The investigator advances cardiac imaging applications in clinical practice, particularly utilizing CT scanning technology for cardiovascular risk assessment. Their work integrates modern imaging techniques with therapeutic decision-making.

  • Cardiac CT Scanning
  • Risk Assessment Protocols
  • Treatment Strategy Optimization

Their research emphasizes evidence-based screening approaches for early disease detection and intervention.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.